Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Magna International Inc MGA Q1 2026 Earnings EPS Blows Past Estimates Stock Gains 236 CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158 NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline FCRX Q1 2026 Earnings Slight EPS Miss Reflects Steady Performance Amid Stable Market Conditions SMC Q1 2026 Earnings EPS Beats Estimates but Stock Declines 778